James Maliszewski
Internal Medicine · Kansas City, MONPI 1902897903
Payments from drug & device makers
Across 168 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$315
- Pfizer$312
- Amgen$278
- Lilly USA, LLC$212
- Foundation Medicine, Inc.$202
- Novo Nordisk$179
- plus $942 from 21 others
What the payments were for
- Speaking & faculty fees$2028%
- Food & beverage$2,23792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $315 |
| Pfizer | 32 | $312 |
| Amgen | 18 | $278 |
| Lilly USA, LLC | 16 | $212 |
| Foundation Medicine, Inc. | 1 | $202 |
| Novo Nordisk | 12 | $179 |
| AstraZeneca | 8 | $101 |
| Merck | 7 | $97 |
| Eisai Inc. | 6 | $87 |
| Astellas Pharma US Inc | 5 | $80 |
| Johnson & Johnson(2 entities) | 5 | $78 |
| Abbott | 3 | $62 |
| GSK | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Teva Pharmaceuticals USA, Inc. | 4 | $50 |
| Boehringer Ingelheim | 3 | $49 |
| Novartis | 3 | $43 |
| Sanofi Pasteur Inc. | 3 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Amarin Pharma, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| UCB, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Ironwood Pharmaceuticals, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,439 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Kansas City
- Craig DietzKansas City$4M
- Santosh SharmaKansas City$782K
- Kevin SuttmoellerKansas City$198K
- Karla Houston-GrayKansas City$24K
- Timothy SmithSaint Peters$21.4M
- Michael ReschakSaint Louis$3.1M
- Dima DandachiColumbia$1.2M
- Jianbo WangChesterfield$643K
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.